Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study

BACKGROUND: The BNT162b2 mRNA (Pfizer–BioNTech) and ChAdOx1 nCoV-19 (Oxford–AstraZeneca) COVID-19 vaccines have shown high efficacy against disease in phase 3 clinical trials and are now being used in national vaccination programmes in the UK and several other countries. Studying the real-world effe...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Lancet
Κύριοι συγγραφείς: Vasileiou, Eleftheria, Simpson, Colin R, Shi, Ting, Kerr, Steven, Agrawal, Utkarsh, Akbari, Ashley, Bedston, Stuart, Beggs, Jillian, Bradley, Declan, Chuter, Antony, de Lusignan, Simon, Docherty, Annemarie B, Ford, David, Hobbs, FD Richard, Joy, Mark, Katikireddi, Srinivasa Vittal, Marple, James, McCowan, Colin, McGagh, Dylan, McMenamin, Jim, Moore, Emily, Murray, Josephine LK, Pan, Jiafeng, Ritchie, Lewis, Shah, Syed Ahmar, Stock, Sarah, Torabi, Fatemeh, Tsang, Ruby SM, Wood, Rachael, Woolhouse, Mark, Robertson, Chris, Sheikh, Aziz
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Elsevier 2021
Θέματα:
Articles
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8064669/
https://ncbi.nlm.nih.gov/pubmed/33901420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(21)00677-2
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια